Abstract

Inpatient dermatology is an emerging subspecialty; however, outcomes of patients treated by inpatient dermatologists have not been described on a national level. Our objective was to answer the following question: are inpatient dermatology services associated with differences in risk-adjusted mortality, readmissions, length of stay, or cost? We used a 100% sample of the 2016-2018 CMS Inpatient Standard Analytic File and Master Beneficiary Summary File to evaluate 30,900 consecutive inpatient dermatology discharges (as defined by MS-DRG 595, 596, 606, 607) at 1912 teaching hospitals from January 2016 through November 31, 2018.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call